Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Severe Eosinophilic Asthma
Agamemnon Bakakos, Stelios Loukides, Petros Bakakos
Journal of Clinical Medicine (2019) Vol. 8, Iss. 9, pp. 1375-1375
Open Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Eosinophilic and Noneosinophilic Asthma
Liam G. Heaney, Luis Pérez de Llano, Mona Al‐Ahmad, et al.
CHEST Journal (2021) Vol. 160, Iss. 3, pp. 814-830
Open Access | Times Cited: 179
Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness
Denisa Ferastraoaru, Golda Hudes, Elina Jerschow, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 3, pp. 1152-1162.e3
Open Access | Times Cited: 149
Modulating Th2 Cell Immunity for the Treatment of Asthma
Beatriz León, André Ballesteros‐Tato
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 146
Influence of aeroallergen sensitization and nasal polyposis on mepolizumab response in eosinophilic severe asthma
Fatma Arzu Akkus, Fatih Çölkesen, Tuğba Önalan, et al.
Allergy and Asthma Proceedings (2025) Vol. 46, Iss. 2, pp. 119-125
Closed Access | Times Cited: 1
The relationship between asthma, eosinophilia, and outcomes in coronavirus disease 2019 infection
Kam Sing Ho, Daniel Howell, Linda Rogers, et al.
Annals of Allergy Asthma & Immunology (2021) Vol. 127, Iss. 1, pp. 42-48
Open Access | Times Cited: 59
Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study
Laura Pini, Diego Bagnasco, Bianca Beghè, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 10, pp. 3013-3013
Open Access | Times Cited: 8
Mepolizumab effectiveness on small airway obstruction, corticosteroid sparing and maintenance therapy step-down in real life
Bruno Sposato, Gianna Camiciottoli, Elena Bacci, et al.
Pulmonary Pharmacology & Therapeutics (2020) Vol. 61, pp. 101899-101899
Open Access | Times Cited: 55
ChAracterization of ItaliaN severe uncontrolled Asthmatic patieNts Key features when receiving Benralizumab in a real-life setting: the observational rEtrospective ANANKE study
Francesco Menzella, Elena Bargagli, Maria Aliani, et al.
Respiratory Research (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 28
Eosinophilic Airway Diseases: From Pathophysiological Mechanisms to Clinical Practice
Mauro Mormile, Ilaria Mormile, Salvatore Fuschillo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7254-7254
Open Access | Times Cited: 20
Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study
Alessandra Vultaggio, Maria Aliani, Elena Altieri, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 20
Pericytes: The lung-forgotten cell type
Annelise T. Garrison, R.E. Bignold, Xinhui Wu, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 18
Blood-Based Biomarkers for Eosinophilic Esophagitis and Concomitant Atopic Diseases: A Look into the Potential of Extracellular Vesicles
Elena Grueso-Navarro, Pilar Navarro, Emilio J. Laserna‐Mendieta, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3669-3669
Open Access | Times Cited: 16
Neutrophil Extracellular Trapping Network Promotes the Pathogenesis of Neutrophil-associated Asthma through Macrophages
Xi Chen, Yuanyuan Li, Ling Qin, et al.
Immunological Investigations (2020) Vol. 50, Iss. 5, pp. 544-561
Closed Access | Times Cited: 41
Biological Therapy of Severe Asthma and Nasal Polyps
Agamemnon Bakakos, Florence Schleich, Petros Bakakos
Journal of Personalized Medicine (2022) Vol. 12, Iss. 6, pp. 976-976
Open Access | Times Cited: 24
Proteomic signatures of eosinophilic and neutrophilic asthma from serum and sputum
Khezia Asamoah, Kian Fan Chung, Nazanin Zounemat Kermani, et al.
EBioMedicine (2023) Vol. 99, pp. 104936-104936
Open Access | Times Cited: 13
Biologics for asthma and risk of pneumonia
Maria Gabriella Matera, Josuel Ora, Luigino Calzetta, et al.
Journal of Asthma (2024) Vol. 61, Iss. 9, pp. 905-911
Closed Access | Times Cited: 4
Proposal of a New Composite Score (DAMADECO) to Simultaneously Evaluate Asthma and CRSwNP Severity in Comorbid Patients
Maria D’Amato, Patrizio Pasqualetti, Elena Cantone, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 957-957
Open Access
TLR7/8 signaling activation enhances the potency of human pluripotent stem cell-derived eosinophils in cancer immunotherapy for solid tumors
Sheng Zhu, Zhengyang Zhou, Riliang Gu, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Durability of benralizumab effectiveness in severe eosinophilic asthma patients with and without chronic rhinosinusitis with nasal polyps: a post hoc analysis from the ANANKE study
Luisa Brussino, Maria Aliani, Elena Altieri, et al.
Frontiers in Allergy (2025) Vol. 6
Open Access
Younger severe asthma patients with interleukin 4 (CC variant) and dupilumab treatment are more likely to achieve clinical remission
Mona Al‐Ahmad, Asmaa Ali, Wafaa Talat
BMC Pulmonary Medicine (2025) Vol. 25, Iss. 1
Open Access
The Role of Dupilumab in Severe Asthma
Fabio Luigi Massimo Ricciardolo, Francesca Bertolini, Vitina Carriero
Biomedicines (2021) Vol. 9, Iss. 9, pp. 1096-1096
Open Access | Times Cited: 30
Nutraceuticals: unlocking newer paradigms in the mitigation of inflammatory lung diseases
Yinghan Chan, Venkata Sita Rama Raju Allam, Keshav Raj Paudel, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 63, Iss. 19, pp. 3302-3332
Closed Access | Times Cited: 28
Efficacy and Safety of Masitinib in Corticosteroid-Dependent Severe Asthma: A Randomized Placebo-Controlled Trial
Lavinia Davidescu, G. Ursol, Oleksii Korzh, et al.
Journal of Asthma and Allergy (2022) Vol. Volume 15, pp. 737-747
Open Access | Times Cited: 19
Real-World Effectiveness Study of Benralizumab for Severe Eosinophilic Asthma: ZEPHYR 2
Donna Carstens, Diego J. Maselli, Mu Fan, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 7, pp. 2150-2161.e4
Closed Access | Times Cited: 12
Role of Type2 Inflammatory Biomarkers in Chronic Obstructive Pulmonary Disease
Keiji Oishi, Kazuto Matsunaga, Toshihiro Shirai, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 8, pp. 2670-2670
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top